ArticleArthritis research & therapy2012

The anti-CD74 humanized monoclonal antibody, milatuzumab, which targets the invariant chain of MHC II complexes, alters B-cell proliferation, migration, and adhesion molecule expression.

Daniela Frölich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.